Viewing Study NCT02483104

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:55 PM
Ignite Modification Date: 2026-02-20 @ 10:45 PM
Study NCT ID: NCT02483104
Status: COMPLETED
Last Update Posted: 2017-11-20
First Post: 2015-06-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer
Sponsor: AbbVie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ABT-888 View
None BRCA View
None Primary peritoneal cancer View
None carboplatin View
None Fallopian tube View
None Poly (ADP-ribose) polymerase (PARP) View
None paclitaxel View
None Ovarian cancer View
None veliparib View